Indivior Future Growth
Future criteria checks 4/6
Indivior is forecast to grow earnings and revenue by 49.4% and 5.5% per annum respectively. EPS is expected to grow by 46.7% per annum. Return on equity is forecast to be 203.4% in 3 years.
Key information
49.4%
Earnings growth rate
46.7%
EPS growth rate
Pharmaceuticals earnings growth | 23.9% |
Revenue growth rate | 5.5% |
Future return on equity | 203.4% |
Analyst coverage | Good |
Last updated | 25 Oct 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,210 | 317 | 272 | 311 | 5 |
12/31/2025 | 1,101 | 189 | 145 | 209 | 7 |
12/31/2024 | 1,157 | 75 | 120 | 16 | 7 |
9/30/2024 | 1,182 | -3 | -273 | -240 | N/A |
6/30/2024 | 1,147 | -141 | -279 | -227 | N/A |
3/31/2024 | 1,124 | 5 | -383 | -334 | N/A |
12/31/2023 | 1,093 | 2 | -368 | -315 | N/A |
9/30/2023 | 1,042 | -235 | -89 | -52 | N/A |
6/30/2023 | 1,002 | -59 | -22 | -11 | N/A |
3/31/2023 | 947 | -50 | 23 | 35 | N/A |
12/31/2022 | 901 | -53 | -9 | -4 | N/A |
9/30/2022 | 882 | 166 | 176 | 181 | N/A |
6/30/2022 | 838 | 152 | 160 | 145 | N/A |
3/31/2022 | 818 | 166 | 175 | 189 | N/A |
12/31/2021 | 791 | 205 | 339 | 353 | N/A |
9/30/2021 | 753 | 156 | 101 | 115 | N/A |
6/30/2021 | 725 | 139 | 81 | 115 | N/A |
3/31/2021 | 674 | 95 | 39 | 42 | N/A |
12/31/2020 | 647 | -148 | -197 | -193 | N/A |
9/30/2020 | 595 | -190 | -84 | -82 | N/A |
6/30/2020 | 634 | -152 | -70 | -69 | N/A |
3/31/2020 | 700 | -95 | -131 | -130 | N/A |
12/31/2019 | 785 | 134 | 148 | 151 | N/A |
9/30/2019 | 889 | 213 | 217 | 200 | N/A |
6/30/2019 | 935 | 254 | 281 | 275 | N/A |
3/31/2019 | 988 | 248 | 401 | 413 | N/A |
12/31/2018 | 1,005 | 275 | 299 | 303 | N/A |
9/30/2018 | 1,033 | 106 | 247 | 276 | N/A |
6/30/2018 | 1,064 | 67 | N/A | 210 | N/A |
3/31/2018 | 1,083 | 71 | N/A | 260 | N/A |
12/31/2017 | 1,093 | 58 | N/A | 295 | N/A |
9/30/2017 | 1,087 | 281 | N/A | 360 | N/A |
6/30/2017 | 1,080 | 81 | N/A | 409 | N/A |
3/31/2017 | 1,065 | 65 | N/A | 370 | N/A |
12/31/2016 | 1,058 | 35 | N/A | 407 | N/A |
9/30/2016 | 1,047 | -6 | N/A | 326 | N/A |
6/30/2016 | 1,028 | 191 | N/A | 283 | N/A |
3/31/2016 | 1,021 | 201 | N/A | 252 | N/A |
12/31/2015 | 1,014 | 228 | N/A | 320 | N/A |
9/30/2015 | 1,037 | 268 | N/A | 300 | N/A |
6/30/2015 | 1,058 | 314 | N/A | 369 | N/A |
3/31/2015 | 1,085 | 361 | N/A | 530 | N/A |
12/31/2014 | 1,115 | 403 | N/A | 440 | N/A |
9/30/2014 | 1,147 | 443 | N/A | 572 | N/A |
12/31/2013 | 1,216 | 489 | N/A | 791 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INDV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: INDV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: INDV is expected to become profitable in the next 3 years.
Revenue vs Market: INDV's revenue (5.5% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: INDV's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INDV's Return on Equity is forecast to be very high in 3 years time (203.4%).